Pharmacology Management in Improving Exercise Capacity of Patients with Fontan Circulation: A Systematic Review and

Brian Mendel1,2, Christianto1, Moira Setiawan1

  • 1Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.

Insights

Bosentan treatment may improve exercise capacity in Fontan procedure patients by enhancing functional class and reducing heart rate. Further research is needed to fully understand its benefits for these patients.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Clinical Pharmacology

Background:

  • The Fontan procedure is a critical intervention for single ventricle physiology.
  • Long-term complications of the Fontan procedure significantly impact patient quality of life.
  • Improving exercise capacity is a key goal for managing Fontan patients.

Approach:

  • A meta-analysis was conducted following PRISMA guidelines.
  • Included studies were assessed for quality using the STROBE statement.
  • Effectiveness of pharmacologic agents on exercise capacity in Fontan circulation was compared.

Key Points:

  • Bosentan treatment significantly improved New York Heart Association Functional Class (NYHA FC) in Fontan patients.
  • Neither bosentan nor sildenafil showed significant improvement in maximal oxygen consumption (VO2 max).
  • Bosentan decreased post-exercise heart rate and improved 6-minute walking test results.

Conclusions:

  • Bosentan may offer benefits for Fontan circulation patients, indirectly enhancing exercise capacity.
  • Improvements include better NYHA FC and 6-minute walking test performance.
  • More research is necessary to optimize exercise capacity in Fontan patients.
Abstract

Related Concept Videos

Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...